BioAge Labs Inc (NASDAQ: BIOA) is -71.76% lower on its value in year-to-date trading and has touched a low of $3.85 and a high of $26.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BIOA stock was last observed hovering at around $4.30 in the last trading session, with the day’s gains setting it 0.87%.
Currently trading at $5.17, the stock is -58.01% and -71.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.55 million and changing 20.23% at the moment leaves the stock -72.37% off its SMA200. The firm has a 50-day simple moving average (SMA 50) of $18.6028 and a 200-day simple moving average (SMA200) of $18.940338.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -73.03% in the last 1 month, and is 12.64% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.50% over the week and 10.57% over the month.
Distance from 52-week low is 34.29% and -80.58% from its 52-week high.
The shares outstanding are 34.20M, and float is at 20.46M with Short Float at 11.79%.
BioAge Labs Inc (BIOA) Insider Activity
The most recent transaction is an insider purchase by Pande Vijay Satyanand, the company’s Director. SEC filings show that Pande Vijay Satyanand bought 126,793 shares of the company’s common stock on Oct 01 ’24 at a price of $19.73 per share for a total of $2.5 million. Following the purchase, the insider now owns 1.03 million shares.
BioAge Labs Inc disclosed in a document filed with the SEC on Oct 02 ’24 that Pande Vijay Satyanand (Director) bought a total of 67,096 shares of the company’s common stock. The trade occurred on Oct 02 ’24 and was made at $19.73 per share for $1.32 million. Following the transaction, the insider now directly holds 1.09 million shares of the BIOA stock.
Still, SEC filings show that on Oct 03 ’24, Pande Vijay Satyanand (Director) acquired 25,306 shares at an average price of $19.90 for $0.5 million. The insider now directly holds 1,119,195 shares of BioAge Labs Inc (BIOA).
